Live tape
Top 8, mentions 7d6,961GOOGL1,299 mentions▲ +0.03NKE1,072 mentions+0.01AAPL1,051 mentions▲ +0.06NVDA961 mentions▲ +0.08TSLA783 mentions▲ +0.06META711 mentions▲ +0.05LULU561 mentions▲ +0.03VOO523 mentions▲ +0.09

Equity · Healthcare

DNA

Ginkgo Bioworks Holdings, Inc. · NYSE

$6.79 −2.23% 1D Finazon · prior-day close · Sep 9, 2026

Reddit mentioned DNA 1 times in the 30 days to 10 September 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 0% bearish and 100% neither. Reddit data updated 10 September 2026.

Price · Chart
Our own end-of-day closes 46 sessions
$12 $6 12 Jun 9 Sep

The line runs $7.89 on 12 June through $6.79 on 9 September, on a scale from $6 to $12. Days the market did not trade hold the previous close, flat.

The chart above plots the price of DNA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 46 sessions over that window: $7.89 on 12 June 2026 through $6.79 on 9 September 2026.

Market cap $376.6M
52-week range $5 – $16.15
Avg volume 129.2K
Mentions · 30d 1

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 10, 2026

DNA · crowd attention × price

Share ↗
1 mentions

Day27 Aug 2026

MENTIONS10–2 / day
PRICE$7.26$6.5–$8.5Source: Finazon
DNA over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day012usd$6.5$7.0$7.5$8.0$8.512 Aug19 Aug27 Aug3 Sep10 Sep
DNA over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.12 Aug27 Aug10 Sep
The Distributed Sentinel 10 Sep 2026

DNA drew 1 Reddit mentions over the 30 days to 10 September 2026

This chart in words

The chart plots daily Reddit mentions of DNA over the 30 days to 10 September 2026: 1 in total, busiest on 27 August with 1, and 1 on the last day counted. The line is the daily close over the same window: $7 on 24 August, $6.79 on 9 September. Of those days, 12 were trading sessions and the other 18 are hatched on the chart. On 5 of them no session took place, and the last close before it is carried forward rather than plotted; on 4 of them no session took place, and this window holds no earlier close to carry forward; on 9 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Finazon · prior-day close, most closes dollar-rounded at the source

Crowd sentiment on DNA · 30d

n = 1 scored · Method

1 mention of DNA was scored for sentiment in these 30 days, so that one reading IS the sample. A bullish or bearish share of it could only ever read 0% or 100%, which states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where DNA is discussed

(30d)
r/wallstreetbets 100% 1 −0.02

DNA insider trades

SEC Form 4 · last 90 days · newest reported trade 24 Aug 2026
Open-market buys 0
Open-market sells 2
Net sold $8K
Non-trade filings 2
Date Insider Type Shares Value
24 Aug 2026 Coen Steven P. See remarks Sell 330 $2K
17 Jul 2026 Coen Steven P. See remarks Sell 752 $6K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
21 Aug 2026 Coen Steven P. See remarks Option exercise 743
16 Jul 2026 Coen Steven P. See remarks Option exercise 1,486

DNA reported financials

SEC EDGAR XBRL

DNA reported revenue of $170.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$312.8M.

Figure Reported Period
Revenue $170.2M 31 Dec 2025 fiscal year
Net income −$312.8M 31 Dec 2025 fiscal year
Diluted EPS −$5.64 31 Dec 2025 fiscal year
Total assets $990.0M 30 Jun 2026 at period end
Total equity $420.3M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

DNA earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $20M
31 Mar 2026 Q1 2026 $19M
31 Dec 2025 FY 2025 $-5.64 $170M
30 Sep 2025 Q3 2025 $-1.45 $39M
30 Jun 2025 Q2 2025 $-1.10 $39M
31 Mar 2025 Q1 2025 $-1.68 $38M
31 Dec 2024 FY 2024 $-10.54 $227M
30 Sep 2024 Q3 2024 $-1.08 $89M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

DNA institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a DNA position for the quarter ended 30 Jun 2026 — a combined $61.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Viking Global Investors Held (±25%) 3,577,128 $35.4M
Millennium Management Added +30.9% shares 638,676 $6.3M
AQR Capital Management Added +110.9% shares 621,625 $6.2M
Renaissance Technologies Added +437.4% shares 539,856 $5.3M
Tudor Investment Corp Trimmed −27.8% shares 335,710 $3.3M
D. E. Shaw & Co. Added +457.1% shares 151,356 $1.5M
Citadel Advisors New position 130,935 $1.3M
Marshall Wace New position 77,937 $772K
Two Sigma Investments Held (±25%) −5.0% shares 60,454 $599K
Man Group Trimmed −77.8% shares 24,208 $240K

Source: SEC EDGAR 13F filings

DNA fails-to-deliver

SEC CNS data

On 07 Aug 2026, 568 shares of DNA failed to deliver (about $5K).

Settlement date Shares failed Notional % of shares out
07 Aug 2026 568 $5K 0.001%
04 Aug 2026 1,968 $18K 0.004%
03 Aug 2026 1,379 $11K 0.002%

Source: SEC fails-to-deliver (CNS) data

DNA — frequently asked questions

From live data

Is Reddit bullish or bearish on DNA?

Across 1 classified DNA mentions in the last 30 days, 0% read bullish, 0% bearish and 100% neutral. Crowd sentiment is a social signal, not investment advice.

When did DNA last report earnings?

Ginkgo Bioworks Holdings (DNA) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

Are DNA insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 2 sells by DNA insiders on the open market. A further 2 filings were grants, awards, gifts or exercises rather than open-market trades.

What exchange is DNA listed on?

Ginkgo Bioworks Holdings trades on NYSE under the ticker DNA.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.